Pharmerica Corporation (NYSE: PMC) and McKesson Corporation (NYSE:MCK) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership.
Insider and Institutional Ownership
94.3% of Pharmerica Corporation shares are held by institutional investors. Comparatively, 86.6% of McKesson Corporation shares are held by institutional investors. 5.0% of Pharmerica Corporation shares are held by company insiders. Comparatively, 1.2% of McKesson Corporation shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
This is a summary of current ratings and recommmendations for Pharmerica Corporation and McKesson Corporation, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Pharmerica Corporation presently has a consensus price target of $29.25, indicating a potential upside of 0.69%. McKesson Corporation has a consensus price target of $169.50, indicating a potential upside of 16.10%. Given McKesson Corporation’s stronger consensus rating and higher possible upside, analysts plainly believe McKesson Corporation is more favorable than Pharmerica Corporation.
Volatility and Risk
Pharmerica Corporation has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, McKesson Corporation has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500.
This table compares Pharmerica Corporation and McKesson Corporation’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
McKesson Corporation pays an annual dividend of $1.12 per share and has a dividend yield of 0.8%. Pharmerica Corporation does not pay a dividend. McKesson Corporation pays out 5.0% of its earnings in the form of a dividend. Pharmerica Corporation has raised its dividend for 4 consecutive years.
Valuation and Earnings
This table compares Pharmerica Corporation and McKesson Corporation’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Pharmerica Corporation||$2.21 billion||0.41||$133.00 million||$0.74||39.26|
|McKesson Corporation||$199.85 billion||0.15||$3.94 billion||$22.42||6.51|
McKesson Corporation has higher revenue and earnings than Pharmerica Corporation. McKesson Corporation is trading at a lower price-to-earnings ratio than Pharmerica Corporation, indicating that it is currently the more affordable of the two stocks.
McKesson Corporation beats Pharmerica Corporation on 10 of the 17 factors compared between the two stocks.
Pharmerica Corporation Company Profile
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.
McKesson Corporation Company Profile
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.
Receive News & Ratings for Pharmerica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmerica Corporation and related companies with MarketBeat.com's FREE daily email newsletter.